| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |